The School of Chemistry, The University of Manchester, Manchester, M13 9PL, UK.
Org Biomol Chem. 2012 Oct 21;10(39):7952-64. doi: 10.1039/c2ob26310f.
Two syntheses of the C(7)–C(16)-fragment 41 of epothilone D 2 were developed that were based on tin(IV) bromide mediated reactions of 5,6-difunctionalised hex-2-enylstannanes with aldehydes. In the first synthesis, (5S)-6-tert-butyldimethylsilyloxy-5-hydroxy-2-methylhex-2-enyl(tributyl)stannane 20 was reacted with (E)-but-2-enal to give (2S,7R,4Z,8E)-1-tert-butyldimethylsilyloxy-5-methyldeca-4,8-diene-2,7-diol 26 containing ca. 20% of its (7S)-epimer. Following desilylation, the crystalline (2S,7R)-triol 32 was protected as its acetonide 33 and esterified to give the (4-methoxybenzyloxy)acetate 34. An Ireland–Claisen rearrangement of this ester gave methyl (2R,3S,10S,4E,7Z)-3,7-dimethyl-10,11-(dimethylmethylene)dioxy-2-(4-methoxybenzyloxy)undeca-4,7-dienoate 35 that was converted into (2S,9S,6Z)-2,6-dimethyl-9,10-(dimethylmethylene)dioxydec-6-en-1-ol 41 by regioselective alkene manipulation, ester reduction and cleavage of the resulting terminal diol 40 with a reductive work-up. The second synthesis involved the tin(IV) bromide mediated reaction between the stannane 20 and (3S)-4-(4-methoxybenzyloxy)-3-methylbutanal 44 that gave (2S,7S,9S,4Z)-1-tert-butyldimethylsilyloxy-5,9-dimethyl-10-(4-methoxybenzyloxy)dec-4-ene-2,7-diol 45 containing ca. 20% of its (7R)-epimer. After desilylation and protection of the vicinal diol as its acetonide 46, a Barton–McCombie reductive removal of the remaining hydroxyl group gave the (2S,9S,6Z)-2,6-dimethyl-9,10-(dimethylmethylene)dioxydec-6-en-1-ol 41 after oxidative removal of the PMB-ether. The first of these syntheses uses just one chiral starting material, but the second is shorter and more convergent. It was therefore modified by the use of (5S)-6-tert-butyldimethylsilyloxy-5-(2-trimethylsilylethoxy)methoxy-2-methylhex-2-enyl(tributyl)stannane 49 that reacted with (3S)-4-(4-methoxybenzyloxy)-3-methylbutanal 44 to give a 50:50 mixture of the C(4)-epimers of (2S,9S,6Z)-10-tert-butyldimethylsilyloxy-1-(4-methoxybenzyloxy)-2,6-dimethyl-9-(2-trimethylsilylethoxy)methoxydec-6-en-4-ol 50 with high fidelity for formation of the (Z)-alkene. Following the Barton–McCombie deoxygenation, the product 52 was taken through to (2S,9S,6Z,10E)-2,6,10-trimethyl-11-(2-methyl-1,3-thiazol-4-yl)-9-(2-trimethylsilylethoxy)methoxyundeca-6,10-dienal 59 that corresponded to the fully functionalised C(7)–C(17) fragment of epothilone D 2. A precedented stereoselective aldol condensation followed by O-protection, selective deprotection, oxidation and macrocyclisation then gave the macrolide 71 that was deprotected to complete a synthesis of epothilone D 2. Finally regio- and stereo-selective epoxidation gave epothilone B 1.
两种合成方法被开发用于合成埃博霉素 D2 的 C(7)–C(16)-片段 41,这两种方法都是基于锡(IV)溴化物介导的 5,6-二官能化己-2-烯基锡烷与醛的反应。在第一种合成方法中,(5S)-6-叔丁基二甲基甲硅氧基-5-羟基-2-甲基己-2-烯基(三丁基)锡烷 20 与(E)-丁-2-烯醛反应,得到含有约 20%其(7S)-对映异构体的(2S,7R,4Z,8E)-1-叔丁基二甲基甲硅氧基-5-甲基癸-4,8-二烯-2,7-二醇 26。在脱硅后,得到的结晶(2S,7R)-三醇 32 被保护为其缩酮 33 并酯化,得到(4-甲氧基苄氧基)乙酸酯 34。该酯的 Ireland–Claisen 重排得到甲酯(2R,3S,10S,4E,7Z)-3,7-二甲基-10,11-(二甲基亚甲基)二氧基-2-(4-甲氧基苄氧基)十一烷-4,7-二烯酸酯 35,该酯通过区域选择性烯烃操作、酯还原和用还原工作液裂解得到的末端二醇 40,转化为(2S,9S,6Z)-2,6-二甲基-9,10-(二甲基亚甲基)二氧基-6-烯-1-醇 41。第二种合成方法涉及锡(IV)溴化物介导的 20 与(3S)-4-(4-甲氧基苄氧基)-3-甲基丁醛 44 之间的反应,得到含有约 20%其(7R)-对映异构体的(2S,7S,9S,4Z)-1-叔丁基二甲基甲硅氧基-5,9-二甲基-10-(4-甲氧基苄氧基)癸-4-烯-2,7-二醇 45。在脱硅和保护邻二醇为其缩酮 46 后,用 Barton–McCombie 还原脱除剩余的羟基,得到氧化脱除 PMB-醚后(2S,9S,6Z)-2,6-二甲基-9,10-(二甲基亚甲基)二氧基-6-烯-1-醇 41。这两种合成方法中的第一种只使用一种手性起始原料,但第二种更短且更收敛。因此,它通过使用(5S)-6-叔丁基二甲基甲硅氧基-5-(2-三甲基甲硅烷基乙氧基)甲氧基-2-甲基己-2-烯基(三丁基)锡烷 49 进行了修饰,该试剂与(3S)-4-(4-甲氧基苄氧基)-3-甲基丁醛 44 反应,得到(2S,9S,6Z)-10-叔丁基二甲基甲硅氧基-1-(4-甲氧基苄氧基)-2,6-二甲基-9-(2-三甲基甲硅烷基乙氧基)甲氧基癸-6-烯-4-醇 50 的 C(4)-差向异构体混合物,其(Z)-烯烃的形成具有高保真度。在 Barton–McCombie 脱氧后,产物 52 被转化为(2S,9S,6Z,10E)-2,6,10-三甲基-11-(2-甲基-1,3-噻唑-4-基)-9-(2-三甲基甲硅烷基乙氧基)甲氧基十一烷-6,10-二烯醛 59,对应于埃博霉素 D2 的完全官能化的 C(7)–C(17)片段。随后进行了一个先例性的立体选择性醛缩合反应,接着进行了 O-保护、选择性脱保护、氧化和大环化反应,得到了大环内酯 71,该大环内酯经脱保护完成了埃博霉素 D2 的合成。最后,区域和立体选择性环氧化得到了埃博霉素 B1。